Skip to content
Spiritual Quotes – Lifestyle
Author:
HUTCHMED (China) Limited
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
April 29, 2026
HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026
April 8, 2026
←
Previous Page
1
2